PPARGC1A and neoplasm: It can play an anti-tumor role by inhibiting pyruvate kinase M2 (PKM2), inhibiting the transcriptionally activated Nrf2 downstream target gene BAG3, and activating PKM2-AMPK-PGC1α signal pathway triggers mitochondrial dysfunction [36] [37,38].